Ms. Haggerty, 41, is the Founder and Executive Director of Common Ground, a
not-for-profit housing development and management organization in New York City
providing innovative housing opportunities for homeless adults. Common Ground
operates several businesses and employment projects to assist tenants in
returning to the work force and enhancing their job skills. In 2001, the
Chicago-based MacArthur Foundation awarded a five-year fellowship to Ms.
Haggerty through its MacArthur Fellows Program.
Prior to founding Common Ground, Ms. Haggerty was the coordinator of housing
development at Brooklyn Catholic Charities, operating in Brooklyn and Queens in
New York City. She currently serves as a Trustee of Amherst College and the
Folger Shakespeare Library; a Director of the Times Square Business Improvement
District; and a Board Member of New York City's Citizens Housing and Planning
Council and the Center for Urban Community Services.
"We are very pleased that Rosanne Haggerty is joining the Board," said Kenneth
W. Freeman, Chairman and Chief Executive Officer of Quest Diagnostics. "She is
an entrepreneur whose many successes stem from an ability to identify creative
approaches to some of society's most challenging problems. Her insights,
experience and creativity will provide a valued perspective."
Quest Diagnostics Incorporated is the nation's leading provider of diagnostic
testing, information and services, providing insights that enable physicians,
hospitals, managed care organizations and other healthcare professionals to make
decisions to improve health. The company offers the broadest access to
diagnostic laboratory testing services through its national network of
laboratories and patient service centers. Quest Diagnostics is the leading
provider of esoteric testing, including gene-based medical testing, and empowers
healthcare organizations and clinicians with state-of-the-art connectivity
solutions that improve practice management. Additional company information can
be found on the Internet at: http://www.questdiagnostics.com.
The statements in this press release that are not historical facts or
information may be forward-looking statements. These forward-looking statements
involve risks and uncertainties that could cause the outcome to be materially
different. Certain of these risks and uncertainties are listed in the Quest
Diagnostics Incorporated 2000 Form 10-K and subsequent filings.
SOURCE Quest Diagnostics Incorporated
CONTACT: Investors - Cathy Doherty, +1-201-393-5030, or Media - Gary
Samuels, +1-201-393-5700, both of Quest Diagnostics Incorporated
URL: http://www.questdiagnostics.com
Copyright (C) 2002 PR Newswire. All rights reserved.